Document is current
Any future updates will be listed below
-
Authors
Wu, Wen-Chuan
Chen, Jiann-Torng
Tsai, Ching-Yao
Wu, Chien-Liang
Cheng, Cheng-Kuo
Shen, Yun-Dun
Tsai, Arslan
Wu, Pei-Chang http://orcid.org/0000-0002-7201-1900
-
Funding
Funding for this research was provided by:
Novartis (Taiwan) Co. Ltd
- License Information
-
More Information
Article History
Received: 1 August 2020
Accepted: 2 November 2020
First Online: 25 November 2020
Ethics approval and consent to participate
: Independent Ethics Committee or Institutional Review Board (IRB) of each participating centre had approved this study.IRB approval numbers for each centre are presented within parentheses: Kaohsiung Medical University Chung-Ho Memorial Hospital [KMUHIRB-2014-02-02(II)]; Municipal Wan Fang Hospital [201403019]; Taipei Medical University-Shung Ho Hospital [201403018]; Shin Kong Wu Ho-Su Memorial Hospital [20131207 M]; Taipei City Hospital [TCHIRB-1030112]; Tri-Service General Hospital, National Defense Medical Centre [1–102–05-141]; Kaohsiung Chang Gung Memorial Hospital [103-0609A3].All patients or their guardians provided their written informed consent to participate in the study.
: Not applicable.Patients or the public WERE NOT involved in the design, or conduct, or reporting, or dissemination plans of our research. Manuscript does not contain any individual person’s data in any form.
: Wen-Chuan Wu: a, bPei-Chang Wu: aChien-Liang Wu: a, bJiann-Torng Chen, Cheng-Kuo Cheng, Ching-Yao Tsai, Yun-Dun Shen: nothing to declarea. Travel has been funded, fully or partially, by a company producing, developing, or supplying the product or procedure presentedb. Travel has been funded, fully or partially, by a competing company.
